The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
The Crisis in Antibiotic Resistance
Abstract
The synthesis of large numbers of antibiotics over the past three decades has caused complacency about the threat of bacterial resistance. Bacteria have become resistant to antimicrobial agents as a result of chromosomal changes or the exchange of the exchange of genetic material via plasmids and transposons. Streptococcus pneumoniae, Streptococcus pyogenes, and staphylococci, organisms that cause respiratory and cutaneous infections, and members of the Enterobacteriaceae and Pseudomonas families, organisms that cause diarrhea, urinary infection, and sepsis, are now resistant to virtually all of the older antibiotics. The extensive use of antibiotics in the community and hospitals has fueled this crisis. Mechanisms such as antibiotic control programs, better hygiene, and synthesis of agents with improved antimicrobial activity need to be adopted in order to limit bacterial resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Overuse and antibiotic resistance have proliferated[422]”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [422]
Citations
Cites
The life and times of the Enterococcus
Murray, B. E. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.1.46 · Cited by 1,887
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 804
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. A. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 776
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 704
Bugg, T. D. H., Wright, G. D., Dutka‐Malen, S., Arthur, M., Courvalin, P. M., & Walsh, C. T. (1991) · Biochemistry · doi:10.1021/bi00107a007 · Cited by 642
Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification
Leclercq, R., & Courvalin, P. M. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.7.1267 · Cited by 629
McMurry, L. M., Petrucci, R., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 606
Antimicrobial resistance of Staphylococcus aureus: genetic basis
Lyon, B. R., & Skurray, R. A. (1987) · Microbiological Reviews · doi:10.1128/mr.51.1.88-134.1987 · Cited by 593
Research works printed but not linked: 30
- AMERICAN JOURNAL OF MEDICINE 91 3B (1991).
- APPELBAUM, P. C., EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 367 (1987).
- BANERJEE, S.N., SECULAR TRENDS IN NOSOCOMIAL PRIMARY BLOOD-STREAM INFECTIONS IN THE UNITED-STATES, 1980-1989, AMERICAN JOURNAL OF MEDICINE 91: S86 (1991).
- BOYCE, J. M., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 249: 2803 (1983). · DOI
- Bryan, L. E., Antimicrobial Drug Resistance 241 (1984).
- BUOHO, A. Y., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 B: 41 (1988).
- BUSH, K, ANTIMICROB AGENTS CH 33: 339 (1989).
- COOKSON, B. D., JOURNAL OF APPLIED BACTERIOLOGY 69: 55S (1990).
- DEGUCHI, K, JAPANESE JOURNAL OF ANTIBIOTICS 42: 2133 (1990).
- Fisher, M., New Antibacterial Strategies 177 (1990).
- Higgins, C. F., New Antibacterial Strategies 193 (1990).
- KHARDORI, N, REVIEWS OF INFECTIOUS DISEASES 12: 996 (1990).
- LUJAN, R, REVISTA ESPANOLA DE QUIMIOTERAPIA 3: 323 (1990).
- McMurry, L., Proceedings of the National Academy of Sciences of the United States of America 77: 3974 (1980).
- MILATOVIC, D, EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES 6: 234 (1987).
- Mitsuhashi, S., The Aminoglycosides 97 (1982).
- MOELLERING, R, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 28: 1 (1991).
- MUDDER, R.R., ARCH INTERN MED 147: 1672 (1987). · DOI
- NEU, H. C., AMERICAN JOURNAL OF MEDICINE 76: 11 (1984).
- NEU, H.C., AMERICAN JOURNAL OF MEDICINE 7 5A: 2 (1985).
- Neu, H. C., Human Pharmacology 613 (1991).
- Normark, S., New Antibacterial Strategies 161 (1990).
- PHILLIPS, I, JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 27: 40 (1991).
- SCHABERG, D. R., AMERICAN JOURNAL OF MEDICINE 91 3B: 725 (1991).
- SKURRAY, R. A., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 21 C: 19 (1988).
- SLOCOMBE, B,JOURNAL OF HOSPITAL INFECTION 19: 19 (1991).
- SMITH, A, INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 5: 177 (1992).
- TALLY, F. P., JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 22 A: 63 (1989).
- TENOVER, F. C., AMERICAN JOURNAL OF MEDICINE 91: S76 (1991).
- UTTLEY, AHC, VANCOMYCIN-RESISTANT ENTEROCOCCI, LANCET 1: 57 (1988).
Cited by
Sorted by citations
Items 201–300 of 1,000
Antimicrobial resistance of Escherichia coliisolates from broiler chickens and humans
Miles, T. D., McLaughlin, W. A., & Brown, P. D. (2006) · BMC Veterinary Research · doi:10.1186/1746-6148-2-7 · Cited by 199
“Background Antibiotic usage is possibly the most important factor that promotes the emergence, selection and dissemination of antibiotic-resistant microorganisms in both veterinary and human medicine [1,2].”
BackgroundAn “On‐Site Transformation” Strategy for Treatment of Bacterial Infection
Qi, G., Zhang, D., Liu, F., Qiao, Z., & Wang, H. (2017) · Advanced Materials · doi:10.1002/adma.201703461 · Cited by 197
Antimicrobial resistance in hospitals: How concerned should we be?
Mulvey, M. R., & Simor, A. E. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080239 · Cited by 198
“Whether antibiotic resistance is intrinsic or acquired, the genetic determinants of resistance encode specific biochemical resistance mechanisms that may include enzymatic inactivation of the drug, alterations to the structure of the antibiotic target site, and changes that prevent access of an adequate concentration…”
BackgroundInfluentialAntimicrobials for acute otitis media? a review from the international primary care network: Table 1
Froom, J., Culpepper, L., Jacobs, M., DeMelker, R. A., Green, L. A., van Buchem, L., Grob, P. R., & Heeren, T. (1997) · BMJ · doi:10.1136/bmj.315.7100.98 · Cited by 197
Gram-positive resistance: challenge for the development of new antibiotics
Baquero, F. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.suppl_1.1 · Cited by 196
Epidemiology of Infections in Cancer Patients
Zembower, T. (2014) · Cancer treatment and research · doi:10.1007/978-3-319-04220-6_2 · Cited by 203
“Because neutrophils play a major role in controlling infections due to Candida and Aspergillus, invasive fungal infections are also frequently encountered in neutropenic patients [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] .”
BackgroundEdiriweera, M. K., Tennekoon, K. H., & Samarakoon, S. R. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/6949835 · Cited by 216
“Unnecessary use of antibiotics for viral infections, prolong use of antibiotics for diseases, wrong prescriptions given to patients without determining the exact cause of infection, and discontinuation of antibiotics without completing treatments by patients are some of the major causes for occurrence of antibiotic re…”
BackgroundRevisiting the mechanistic pathways for bacterial mediated synthesis of noble metal nanoparticles
Ali, J., Ali, N., Wang, L., Waseem, H., & Pan, G. (2019) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2019.02.010 · Cited by 194
“The worldwide upsurge in antibiotic resistance has become 363 a severe concern for modern medicine (Goossens et al., 2005, Neu, 1992, Yelin and Kishony, 364 2018).”
BackgroundVancomycin Resistance: Decoding the Molecular Logic
Walsh, C. T. (1993) · Science · doi:10.1126/science.8392747 · Cited by 194
SUNDIN, G. W., & BENDER, C. L. (1996) · Molecular Ecology · doi:10.1111/j.1365-294x.1996.tb00299.x · Cited by 195
Markin, D., Duek, L., & Berdicevsky, I. (2003) · Mycoses · doi:10.1046/j.1439-0507.2003.00859.x · Cited by 193
Arokiyaraj, S., Saravanan, M., Prakash, N. K. U., Arasu, M. V., Badathala, V., & Vincent, S. (2013) · Materials Research Bulletin · doi:10.1016/j.materresbull.2013.05.059 · Cited by 191
Lobkovsky, E. B., Moews, P. C., Liu, H., Zhao, H., Frère, J., & Knox, J. R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11257 · Cited by 191
Engineering nanosilver as an antibacterial, biosensor and bioimaging material
Sotiriou, G. A., & Pratsinis, S. E. (2011) · Current Opinion in Chemical Engineering · doi:10.1016/j.coche.2011.07.001 · Cited by 191
“Several bacteria, however, start exhibiting resistance to antibiotics [41] so materials for passive protection are sought that exhibit bactericidal properties such as nanosilver and/or photoactive titania.”
BackgroundHuman Diseases Caused by Foodborne Pathogens of Animal Origin
Swartz, M. N. (2002) · Clinical Infectious Diseases · doi:10.1086/340248 · Cited by 190
Controlling Bacterial Biofilms
Richards, J. J., & Melander, C. (2009) · ChemBioChem · doi:10.1002/cbic.200900317 · Cited by 206
Kaye, K. S., Engemann, J. J., Fraimow, H. S., & Abrutyn, E. (2004) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2004.04.003 · Cited by 181
“Methicillin resistance in staphylococci is most commonly mediated by the mecA gene, which encodes for a single additional PBP, PBP2a, with low affinity for all b-lactams [1,7].”
InfluentialAntibacterial Agents That Target Lipid A Biosynthesis in Gram-negative Bacteria
Jackman, J. E., Fierke, C. A., Tumey, L. N., Pirrung, M. C., Uchiyama, T., Tahir, S. H., Hindsgaul, O., & Raetz, C. R. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.15.11002 · Cited by 187
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186
“Overuse and antibiotic resistance have proliferated [422] to the point that the U.”
BackgroundKhalafi‐Nezhad, A., Rad, M. N. S., Mohabatkar, H., Asrari, Z., & Hemmateenejad, B. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.01.014 · Cited by 187
Kondejewski, L. H., Farmer, S. W., Wishart, D. S., Kay, C. M., HANCOCK, R. E. W., & Hodges, R. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25261 · Cited by 186
Wang, Y., Ding, X., Chen, Y., Guo, M., Zhang, Y., Guo, X., & Gu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.004 · Cited by 185
Ariza, R. R., Li, Z., Ringstad, N., & Demple, B. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.7.1655-1661.1995 · Cited by 185
“Multiple antibiotic resistance in bacteria is an increasing problem in medical microbiology but is still poorly understood at the molecular level (6, 32).”
BackgroundClinical impact and relevance of antibiotic resistance
French, G. L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.04.005 · Cited by 182
Shan, J., Yang, K., Xiu, W., Qiu, Q., Dai, S., Yuwen, L., Weng, L., Teng, Z., & Wang, L. (2020) · Small · doi:10.1002/smll.202001099 · Cited by 181
The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics
Chopra, I., Hodgson, J., Metcalf, B. J., & Poste, G. H. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.497 · Cited by 180
“In some isolates resistance to the macrolides, quinolones, and tetracyclines is mediated by efflux pumps that prevent antibiotic accumulation by the bacterium (6, 10, 29, 39, 49).”
BackgroundInfluentialAntolini, M., Bozzoli, A., Ghiron, C., Kennedy, G., Rossi, T., & Ursini, A. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00112-2 · Cited by 179
Antimicrobial graphene polymer (PVK-GO) nanocomposite films
Santos, C. M., Tria, M. C. R., Vergara, R. A. M. V., Ahmed, F., Advíncula, R. C., & Rodrigues, D. F. (2011) · Chemical Communications · doi:10.1039/c1cc11877c · Cited by 179
Samonis, G., Maraki, S., Karageorgopoulos, D. E., Vouloumanou, E. K., & Falagas, M. E. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1360-5 · Cited by 179
“Since the era of pandrug resistance for Gram-negative pathogens may not be a scenario for the distant future, and the pace of development of new antimicrobial agents for clinical use is far from encouraging, the identification of novel therapeutic options among the currently available agents seems imperative [1, 2].”
BackgroundFinch, R., Schürmann, D., Collins, O., Kubin, R., McGivern, J., Bobbaers, H., Alonso, J. L. I., Nikolaides, P., Ogundare, F. F., Raz, R., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1746-1754.2002 · Cited by 179
“It is known that no specific cause is found in as many as 30 to 60% of patients even when extensive diagnostic testing is performed (15).”
BackgroundChastre, J. E., & Fagon, J.-Y. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.150.2.8049850 · Cited by 179
Non-antibiotic treatment recommendations: delivery formats and implications for parent resistance
Stivers, T. (2004) · Social Science & Medicine · doi:10.1016/j.socscimed.2004.06.040 · Cited by 180
“Although the US, along with many other developed nations, is facing a large-scale problem with antibiotic resistant bacteria (Baquero, Baquero-Artigao, Canton, & Garcia-Rey, 2002; McCaig & Hughes, 1995; Neu, 1992; Reichler et al., 1992; Schwartz, 1999;”
BackgroundFish, D. N., Piscitelli, S. C., & Danziger, L. H. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04366.x · Cited by 178
A review: benefit and bioactive properties of olive (Olea europaea L.) leaves
Özcan, M. M., & Matthäus, B. (2016) · European Food Research and Technology · doi:10.1007/s00217-016-2726-9 · Cited by 177
Dale, G. E., Broger, C., Arcy, A. D., HARTMAN, P. G., DeHoogt, R., Jolidon, S., Kompis, I. M., Labhardt, A. M., Langen, H., Locher, H. H., et al. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0770 · Cited by 180
“The problem of bacterial resistance to many of todays antimicrobial agents is well known (Cohen, 1992, 1994; Davies, 1994; Neu, 1992; Spratt, 1994).”
BackgroundShiradkar, M. R., Murahari, K. K., Gangadasu, H. R., Tatikonda, S., Akula, K. C., Panchal, D., Kaur, R., Burange, P. J., Ghogare, J., Mokale, V. J., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.04.003 · Cited by 176
Gerard, J. M., Lloyd, R., Barsby, T., Haden, P., Kelly, M. T., & Andersen, R. J. (1997) · Journal of Natural Products · doi:10.1021/np9606456 · Cited by 176
Synergetic effect of vancomycin loaded silver nanoparticles for enhanced antibacterial activity
Kaur, A., Preet, S., Kumar, V., Kumar, R., & Kumar, R. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.12.043 · Cited by 176
Methicillin resistantStaphylococcus aureus(MRSA) in the intensive care unit
Haddadin, A. S., Fappiano, S. A., & Lipsett, P. A. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.921.385 · Cited by 177
Anchor Structure of Staphylococcal Surface Proteins
Ton-That, H., Faull, K. F., & Schneewind, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.22285 · Cited by 173
Antibiotic-impregnated PMMA hip spacers: Current status
Anagnostakos, K., Fürst, O., & Kelm, J. (2006) · Acta Orthopaedica · doi:10.1080/17453670610012719 · Cited by 173
Sum, P., & Petersen, P. J. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00216-4 · Cited by 173
DESIGNING MICROORGANISMS FOR THE TREATMENT OF TOXIC WASTES
Timmis, K. N., Steffan, R. J., & Unterman, R. (1994) · Annual Review of Microbiology · doi:10.1146/annurev.mi.48.100194.002521 · Cited by 171
The dual probiotic and antibiotic nature of Bdellovibrio bacteriovorus
Dwidar, M., Monnappa, A. K., & Mitchell, R. J. (2012) · BMB Reports · doi:10.5483/bmbrep.2012.45.2.71 · Cited by 169
“ance is expected to worsen in the future as the discovery of new classes of antibiotics continues to decrease (51, 52).”
BackgroundA Vesicle Capture Sensor Chip for Kinetic Analysis of Interactions with Membrane-Bound Receptors
Cooper, M. A., Hansson, A., Löfås, S., & Williams, D. H. (2000) · Analytical Biochemistry · doi:10.1006/abio.1999.4389 · Cited by 169
Herrick, J. B., Stuart-Keil, K. G., Ghiorse, W. C., & Madsen, E. L. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.6.2330-2337.1997 · Cited by 169
“, antibiotic resistance [1, 8, 9, 48]) is available, convincing retrospective comparative phylogenetic arguments for gene transfer between naturally occurring microbial populations in their habitats (in situ) can be successfully assembled by detecting incongruent, independent patterns of gene distribution (10, 20, 28,…”
BackgroundThe Origin of Plagues: Old and New
Krause, R. M. (1992) · Science · doi:10.1126/science.257.5073.1073 · Cited by 169
Bacteriophage Therapy: Developments and Directions
Nikolich, M. P., & Filippov, A. A. (2020) · Antibiotics · doi:10.3390/antibiotics9030135 · Cited by 168
“Multidrug resistance combined with the slowing development of new antibiotics over the past few decades [5,6] threatens to further reduce treatment options for previously curable infections, so Western scientific and medical communities are now reengaging to develop phage therapies to help contend with this burgeoning…”
BackgroundEvaluating and Managing Open Skin Wounds: Colonization Versus Infection
Wysocki, A. B. (2002) · AACN Clinical Issues Advanced Practice in Acute & Critical Care · doi:10.1097/00044067-200208000-00005 · Cited by 168
The changing face of odontogenic infections
Storoe, W., Haug, R. H., & Lillich, T. T. (2001) · Journal of Oral and Maxillofacial Surgery · doi:10.1053/joms.2001.24285 · Cited by 167
A model of antibiotic-resistant bacterial epidemics in hospitals
Webb, G. F., D’Agata, E. M. C., Magal, P., & Ruan, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504053102 · Cited by 167
Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily
Kumar, S. H., Mukherjee, M. M., & Varela, M. F. (2013) · International Journal of Bacteriology · doi:10.1155/2013/204141 · Cited by 167
“Several studies have demonstrated the development of antibiotic resistance in pathogenic bacteria during the course of antibiotic treatment which involved efflux pumps [20, 25, 40, 132, 168].”
BackgroundAdverse consequences of neonatal antibiotic exposure
Cotten, C. M. (2016) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000338 · Cited by 167
Antibacterial surface design of biomedical titanium materials for orthopedic applications
Zhang, Y., He, Y., Lin, C., Liu, P., & Cai, K. (2020) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2020.10.066 · Cited by 167
Feng, Y., Tonon, C. C., Ashraf, S., & Hasan, T. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113941 · Cited by 166
Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness
Lenski, R. E., Simpson, S. C., & Nguyen, T. T. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.11.3140-3147.1994 · Cited by 166
“The finding that bacteria can adapt genetically to the burdensome effects of plasmid carriage has potentially serious implications for the persistence of antibiotic-resistant bacteria in nature, which is an important issue for public health (12, 21, 26, 53, 60).”
BackgroundFluorescent Pyrimidine Ribonucleotide: Synthesis, Enzymatic Incorporation, and Utilization
Srivatsan, S. G., & Tor, Y. (2007) · Journal of the American Chemical Society · doi:10.1021/ja066455r · Cited by 165
Zhang, Q., Jia, A., Wan, Y., Liu, H., Wang, K., Peng, H., Dong, Z., & Hu, J. (2014) · Environmental Science & Technology · doi:10.1021/es503700j · Cited by 166
Chua, S. L., Yam, J. K. H., Hao, P., Adav, S. S., Salido, M. M. S., Liu, Y., Givskov, M., Sze, S. K., Tolker‐Nielsen, T., & Yang, L. (2016) · Nature Communications · doi:10.1038/ncomms10750 · Cited by 163
Hydrophobic Vancomycin Derivatives with Improved ADME Properties: Discovery of Telavancin (TD-6424)
Leadbetter, M. R., Adams, S. M., BAZZINI, B., Fatheree, P. R., Karr, D. E., Krause, K. M., Lam, B. M. T., Linsell, M. S., Nodwell, M. B., Pace, J., et al. (2004) · The Journal of Antibiotics · doi:10.7164/antibiotics.57.326 · Cited by 165
EfrAB, an ABC Multidrug Efflux Pump in Enterococcusfaecalis
Lee, E., Huda, M. N., Kuroda, T., Mizushima, T., & Tsuchiya, T. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3733-3738.2003 · Cited by 162
“Microorganisms have developed various mechanisms to resist the toxic effects of antibiotics and other chemicals (6, 18).”
BackgroundEconomics of self‐medication: theory and evidence
Chang, F., & Trivedi, P. K. (2003) · Health Economics · doi:10.1002/hec.841 · Cited by 162
Detecting Biothreat Agents: From Current Diagnostics to Developing Sensor Technologies
Walper, S. A., Lasarte‐Aragonés, G., Sapsford, K. E., Brown, C. W., Rowland, C. E., Breger, J. C., & Medintz, I. L. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00420 · Cited by 163
Volmer, D. A., Mansoori, B. A., & Locke, S. J. (1997) · Analytical Chemistry · doi:10.1021/ac970425c · Cited by 160
Mifsud, E. J., Tan, A. C. L., & Jackson, D. C. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00079 · Cited by 163
“With the development of anti-microbial resistance to antibiotics (4) and the need to update vaccines to accommodate pathogen evolution, the development of alternative forms of prophylactic agents with a broader spectrum of activity has emerged as a field of intense interest to the scientific community.”
BackgroundHorizontal DNA Transfer Mechanisms of Bacteria as Weapons of Intragenomic Conflict
Croucher, N. J., Mostowy, R. J., Wymant, C., Turner, P., Bentley, S. D., & Fraser, C. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002394 · Cited by 168
“Horizontal exchange of DNA is common in many bacterial species [1,2], and it has become clinically relevant in recent decades through facilitating the spread of antimicrobial resistance [3] and evasion of vaccine-induced immunity [4].”
BackgroundLevin, B. R., & Bull, J. J. (1996) · The American Naturalist · doi:10.1086/285884 · Cited by 159
Antimicrobial Use in Defined Populations of Infants and Young Children
Finkelstein, J. A., Metlay, J. P., Davis, R. L., Rifas‐Shiman, S. L., Dowell, S. F., & Platt, R. G. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.4.395 · Cited by 159
Rifaximin: In vitro and in vivo Antibacterial Activity – A Review
Jiang, Z., & DuPont, H. L. (2005) · Chemotherapy · doi:10.1159/000081991 · Cited by 158
The role of vaccines in fighting antimicrobial resistance (AMR)
Jansen, K. U., & Anderson, A. S. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1476814 · Cited by 158
“new generations and classes of antibiotics including methicillin.(2) Treatment of methicillin resistant S.”
BackgroundGillis, J. C., & Brogden, R. N. (1995) · Drugs · doi:10.2165/00003495-199549030-00009 · Cited by 158
Muroi, H., & Kubo, I. (1996) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1996.tb03233.x · Cited by 157
Eleven Worthy Aims for Clinical Leadership of Health System Reform
Berwick, D. M. (1994) · JAMA · doi:10.1001/jama.1994.03520100059034 · Cited by 158
Hume, E. B. H., Baveja, J. K., Muir, B. W., Schubert, T. L., Kumar, N., Kjelleberg, S. J., Griesser, H. J., Thissen, H. W., Read, R., Poole-Warren, L. A., et al. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.048 · Cited by 156
Dead Bugs Don’t Mutate: Susceptibility Issues in the Emergence of Bacterial Resistance
Stratton, C. W. (2003) · Emerging infectious diseases · doi:10.3201/eid0901.020172 · Cited by 159
Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella
Nishino, K., Nikaido, E., & Yamaguchi, A. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.02.002 · Cited by 163
“Bacteria have developed various ways to resist the toxic effects of antibiotics and other drugs [1,2].”
BackgroundMcClerren, A. L., Endsley, S., Bowman, J. L., Andersen, N. H., Guan, Z., Rudolph, J., & Raetz, C. R. H. (2005) · Biochemistry · doi:10.1021/bi0518186 · Cited by 155
“The emergence of multi-drug resistant bacterial pathogens is a growing public health concern (1).”
BackgroundHorizontal Genetic Exchange, Evolution, and Spread of Antibiotic Resistance in Bacteria
Maiden, M. C. J. (1998) · Clinical Infectious Diseases · doi:10.1086/514917 · Cited by 155
“This mechanism, the subject of this been described, including destruction of the antibiotic, as in the hydrolysis of penicillins with b-lactamases; exclusion of review, has led to the emergence of antibiotic resistance in a number of naturally transformable pathogenic bacteria, includthe antibiotic, by changes in the…”
BackgroundGold Nanoparticles: Can They Be the Next Magic Bullet for Multidrug-Resistant Bacteria?
Okkeh, M., Bloise, N., Restivo, E., Vita, L. D., Pallavicini, P., & Visai, L. (2021) · Nanomaterials · doi:10.3390/nano11020312 · Cited by 161
“All this is leading to protracted hospital stays, higher medical costs, and a rise in mortality [4].”
BackgroundOutpatient Use of Erythromycin: Link to Increased Erythromycin Resistance in Group A Streptococci
Seppälä, H., Klaukka, T., Lehtonen, R., NENONEN, E., Finnish Study Group for Antimicrobial Resistance, & Huovinen, P. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1378 · Cited by 152
“However, the worldwide increase in antimicrobial resistance now poses a serious problem [2].”
BackgroundThe structure and mechanism of bacterial type I signal peptidases
Paetzel, M., Dalbey, R., & Strynadka, N. C. J. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00064-4 · Cited by 152
“Considerable resources worldwide are being expended to develop new families of antibiotics against these clinical pathogens (Neu, 1992).”
BackgroundYano, H., Kuga, A., Okamoto, R., Kitasato, H., Kobayashi, T., & Inoue, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1343-1348.2001 · Cited by 152
“The use of broad-spectrum antimicrobial agents has had a profound effect on the emergence of antibiotic resistance (28).”
BackgroundConsideration of some implications of the resistance of biofilms to biocides
Morton, L. H. G., Greenway, D. L. A., Gaylarde, C. C., & Surman, S. (1998) · International Biodeterioration & Biodegradation · doi:10.1016/s0964-8305(98)00026-2 · Cited by 150
Healy, V. L., Lessard, I. A. D., Roper, D. I., Knox, J. R., & Walsh, C. T. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00116-2 · Cited by 150
“The specter of vancomycin-resistant MRSA looms [6–9], whereas vancomycin-resistant enterococci (VRE), which cause high mortality rates, have become a distressingly common reality in hospital settings [10,11].”
BackgroundCreighton, T. (1997) · Biological Chemistry · doi:10.1515/bchm.1997.378.8.731 · Cited by 150
Staphylococcus aureus binding to human nasal mucin
Shuter, J., Hatcher, V. B., & Lowy, F. D. (1996) · Infection and Immunity · doi:10.1128/iai.64.1.310-318.1996 · Cited by 149
“The recent emergence of multiply antibiotic-resistant staphylococci has raised concern that effective antimicrobial regimens may not be available in the near future (25, 28, 47).”
BackgroundMaveyraud, L., Mourey, L., Kotra, L. P., Pédelacq, J. D., Guillet, V., Mobashery, S., & Samama, J. (1998) · Journal of the American Chemical Society · doi:10.1021/ja9818001 · Cited by 149
Nanomaterials for the Photothermal Killing of Bacteria
Yougbaré, S., Mutalik, C., Krisnawati, D. I., Kristanto, H., Jazidie, A., Nuh, M., Cheng, T.-M., & Kuo, T. (2020) · Nanomaterials · doi:10.3390/nano10061123 · Cited by 149
Peng, F., Guo, Y., Isabwe, A., Chen, H., Wang, Y., Zhang, Y., Zhu, Z., & Yang, J. (2020) · Environment International · doi:10.1016/j.envint.2020.105524 · Cited by 147
“to human health, endangering life-saving antibiotic therapies worldwide (Bengtsson-Palme and Larsson, 2015; Neu, 1992; Sommer et al., 2009).”
BackgroundThe effects of salicylate on bacteria
Price, C. T. D., Lee, I., & Gustafson, J. E. (2000) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(00)00042-x · Cited by 147
“[29] H.”
BackgroundInfluentialThankavel, K., Madison, B. M., Ikeda, T., Malaviya, R., Shah, A. H., Arumugam, P. M., & Abraham, S. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119623 · Cited by 146
Wnt/β-Catenin Signaling as a Molecular Target by Pathogenic Bacteria
Silva-García, O., Valdez-Alarcón, J. J., & Baizabal-Aguirre, V. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02135 · Cited by 142
Appropriateness of Antimicrobial Therapy Measured by Repeated Prevalence Surveys
Willemsen, I., Groenhuijzen, A., Bogaers‐Hofman, D., Stuurman, A., van Keulen, P., & Kluytmans, J. A. J. W. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00994-06 · Cited by 145
“Resistance to antimicrobial drugs is a serious and increasing problem throughout the world (9, 10).”
BackgroundNanogels: A novel approach in antimicrobial delivery systems and antimicrobial coatings
Keskin, D., Zu, G., Forson, A. M., Tromp, L., Sjollema, J., & van Rijn, P. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.004 · Cited by 151
“Therefore, it is imperative to develop novel antimicrobial agents and new treatment strategies [155, 156].”
BackgroundHelix Stability Confers Salt Resistance upon Helical Antimicrobial Peptides
Park, I. Y., Cho, J. H., Kim, K. S., Kim, Y.-B., Kim, M. S., & Kim, S. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311418200 · Cited by 145
Talwalkar, A., & Kailasapathy, K. (2004) · PubMed · Cited by 146
Conder, G. A., & Campbell, W. C. (1995) · Advances in Parasitology/Advances in parasitology · doi:10.1016/s0065-308x(08)60069-x · Cited by 144
Lobkovsky, E. B., Billings, E. M., Moews, P. C., Rahil, J. F., Pratt, R. F., & Knox, J. R. (1994) · Biochemistry · doi:10.1021/bi00188a004 · Cited by 144
Parents’ and Physicians’ Views on Antibiotics
Palmer, D. A., & Bauchner, H. (1997) · PEDIATRICS · doi:10.1542/peds.99.6.e6 · Cited by 144
Recycler: an algorithm for detecting plasmids from de novo assembly graphs
Rozov, R., Kav, A. B., Bogumil, D. D., Shterzer, N., Halperin, E., Mizrahi, I., & Ron Shamir, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw651 · Cited by 142
“For instance, antibacterial resistance genes encoded on plasmids have long been known as a major issue for human health in clinical practice [3], but are also one of today’s standard tools in microbiology and genetics when used to select for specific cells [4].”
Background
Metadata
- Authors
- Neu, H. C.
- Affiliations
- Columbia University (US)
- Corresponding author
- Neu, Harold C.
- Venue
- Science
- Published
- 1992-08-21
- Volume
- 257
- Issue
- 5073
- Pages
- 1064-1073
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1980595924
- Cited by
- 2,834
- References
- 109
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 57 · 2023: 71 · 2022: 91 · 2021: 93 · 2020: 123 · 2019: 100 · 2018: 122 · 2017: 123 · 2016: 105 · 2015: 87 · 2014: 95 · 2013: 109 · 2012: 99
- FWCI
- 46.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, bacterial resistance, plasmids, transposable elements, horizontal gene transfer, Streptococcus pneumoniae, Streptococcus pyogenes, Staphylococcus, Enterobacteriaceae, Pseudomonas, antibiotic overuse, hygiene, novel antimicrobial agents
- MeSH terms
- Anti-Bacterial Agents, Bacterial Infections, Cross Infection, Drug Resistance, Microbial, Enterobacteriaceae, Haemophilus influenzae, Humans, Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, Enterococcus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review